Literature DB >> 19813416

Childhood cancers near German nuclear power stations: the ongoing debate.

Ian Fairlie1.   

Abstract

In late 2007, the significant KiKK study (Kinderkrebs in der Umgebung von KernKraftwerken = Childhood Cancer in the Vicinity of Nuclear Power Plants) in Germany reported a 1.6-fold increase in all cancers and a 2.2-fold increase in leukaemias, among children living within 5 km of all German nuclear power stations. The KiKK study by Kaatsch et al. was extensively described in a recent edition of Medicine Conflict and Survival. It has triggered much discussion as to the cause(s) of these increased cancers. This article reports on recent developments on the KiKK study, including responses by German radiation agencies, and recent epidemiological studies near United Kingdom and French nuclear installations. It reflects the current debate and concludes with advice to policy-makers on radiation risks on the relative merits of the KiKK study. An accompanying article outlines a possible explanation for the increased cancers and makes recommendations for future research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19813416     DOI: 10.1080/13623690902943388

Source DB:  PubMed          Journal:  Med Confl Surviv        ISSN: 1362-3699


  3 in total

Review 1.  Cancer in children residing near nuclear power plants: an open question.

Authors:  Giovanni Ghirga
Journal:  Ital J Pediatr       Date:  2010-09-10       Impact factor: 2.638

2.  The risk of leukaemia in young children from exposure to tritium and carbon-14 in the discharges of German nuclear power stations and in the fallout from atmospheric nuclear weapons testing.

Authors:  Richard Wakeford
Journal:  Radiat Environ Biophys       Date:  2014-01-30       Impact factor: 1.925

3.  Cancer risks near nuclear facilities: the importance of research design and explicit study hypotheses.

Authors:  Steve Wing; David B Richardson; Wolfgang Hoffmann
Journal:  Environ Health Perspect       Date:  2010-12-10       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.